Digital Health Webinar

14 September 2021, Webinar.
The digital healthcare ecosystem is evolving with rapid speed. Technologies such as AI, robotics, telemedicine, and precision medicine are a mix of challenges and opportunities. At the Digital Health Webinar, you will be introduced to digital medicine and DTx, novel wearables, data collection methods, regulatory issues, and other topics. Join the full-day conference Digital Health Webinar on September 14 and network with high-level digital health professionals from pharmaceutical companies and organizations such as Novartis, Teva, Roche, Genentech, Merck, Sanofi, BMS, Ipsen, World Health Organization, and Stanford University.

You will automatically receive 14 days of access to the recorded version of the webinar.

At this webinar, you will listen to hot topics like:

1. From Connected Health to Connected Care: Integrating Product, Technology and System- Speaker: Sander Ruitenberg, Global Digital Health Solutions Head, Novartis

2. Machine Learning, Biosensing, and Virtual Reality Technology - Converging to Impact Healthcare - Speaker: Walter Greenleaf, Ph.D. Neuroscientist, Virtual Reality, and Digital Health Expert Stanford University Virtual Human Interaction Lab

3. Regulatory Landscape of Digital Health- Speaker: Nathan Carrington, Head of Digital Health and Innovation

4. Tackling the Burden of Chronic Disease with Digital Health– Speaker: Michael John Miller, Digital Health Technical Advisory Group (DHTAG) Roster of Experts, WHO

5. Privacy and Security Measures to Protect Patient Data in the New Era of Personalized Medicine– Speaker: Basker Gummadi, Instructor, Digital Health and Innovation in Clinical Trials @ UCSD, Senior Director, Digital Therapeutics, Bristol Myers Squibb

6. Cybersecurity for Digital Health– Speaker: Emily Luvison, Lead, Cybersecurity Compliance for Digital Health Technologies, Genentech

7. Realizing the Promise of Digital Health Partnerships– Speaker: Lauren Liutong Li, Global Head of Digital Health, ​Ipsen

8. Digital Pharmaceuticals and why it makes sense! - Speaker: Mark Milton-Edwards, Head of Health Solutions – Digital Health, Teva Pharmaceuticals

By registering for this 1-day conference you will:

  • Learn about the newest Digital Health Projects worldwide
  • Meet and network with the experts from Big Pharma
  • Listen about data management and patient’s privacy
  • Learn about novelties in healthcare regulatory, Artificial Intelligence, and Machine Learning
  • Explore the rise of telemedicine during and post-pandemic
  • Gain insight into innovating patient support and patient engagement
  • Get the certificate of participation
  • Get access to the recorded webinar for 14 days

For further information and to register, please visit:
https://ubiqwebinars.com/digital-health/

About UBIQ Webinars

UBIQ webinars is a virtual conference producer company. Our team works together to create, promote and produce thought-provoking webinars on a wide range of interesting topics. We are available to help you to craft your next professional webinar and spread the idea you have in mind.

Most Popular Now

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

Bayer Acquires Blackford Analysis Ltd. B…

Bayer announced the acquisition of the global strategic imaging AI platform and solutions provider Blackford Analysis Ltd. The acquisition is part of Bayer's strategy to drive innovation in radiology, including...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...

Veradigm Announces Strategic Investment …

Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc., announced an investment in Holmusk, a global behavioral health real-world evidence and data analytics company, as part of Holmusk's $45 million...